Welcome to NCCRED News, May 2023 edition.
The year is in full swing across NCCRED’s growing team and range of projects.
In this edition of the NCCRED News:
NCCRED research spotlight
DARIA’s, 2023 (now monthly!) program
PhD Opportunities now open!
NCCRED’s prompt response network update
Research spotlight
NCCRED drives innovation and builds clinical research capacity through an internal program of clinical research as well as a grants and seed funding program, higher education scholarships program and research fellowships program.
Check out our most recent research highlights:
Strengthening first line telehealth
This study presents the results of a training needs analysis conducted with staff from Australian Alcohol and Other Drug telephone helplines.
These helplines take over 100,000 calls annually in regards to Methamphetamine and Emerging Drugs of Concern.
The role of technology in Methamphetamine Treatment
NCCRED supported mini review finds that technologically assisted interventions for methamphetamine use were most useful for people not already linked with treatment; future research will also explore how technology can be best integrated with existing treatment.
Lisdexamfetamine for Methamphetamine Withdrawal, safety and feasibility (the OLAM study)
This study demonstrated that Lisdexamfetamine is a safe and feasible treatment for methamphetamine withdrawal, further studies including a randomized control trial are required.
NCCRED grant funded research: Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia
Used a co-design approach to contribute to an early warning system for emerging drugs of concern.
DARIA is NCCRED's monthly seminar series showcasing research and innovation in the Alcohol and Other Drug field.
DARIA is at 12pm on the third Monday of every month.
Series 2023
Monday - 15 May 2023 - 12pm AEST
Discontinuation of Opioid Treatment Programs with Dr Thomas Lu
Check out our 2023 program
15 May: Discontinuation of Opioid Treatment Programs
Dr Thomas Lu19 June: Using NSW health data to understand the health and social characteristics of clients reporting amphetamine type substance use; and the use of the Australian Treatment Outcomes Profile (ATOP). Dr Emma Black
Professor Adrian Dunlop17 July: Managing physical health issues for people going through substance dependence treatment and its implications for the AOD workforce.
Dr Briony Osborne21 August: Systematic review on psychosocial interventions for families impacted by substance use.
Clare Rushton18 September: The role of biorhythms in sleep, and the impacts of substance use.
Dr Rowan Ogiel16 October: Overcoming barriers to women accessing treatment for Methamphetamine use (WOMA study).
Dr Nadine Ezard
Are you ready to take the next step in your clinical research career?
NCCRED is currently looking for exceptional candidates for three PhD scholarship positions.
Click the links below for more information.
The Prompt Response Network (PRN) is a national project bringing together existing and emerging early warning networks across the country regarding emerging drugs of concern and enabling a rapid response to reduce harm associated with them.
Kept in the Know
Three alerts were published in May:
NSW Ministry of Health published a drug warning, 5 May 2023: Potent synthetic opioid (isotonitazene) found in yellow powder
The Victorian Department of Health published a drug alert, 5 May 2023: Novel stimulants sold as MDMA, cocaine or speed.
Queensland Health published a drug warning, 2 May 2023: Fake Xanax® tablets containing a strong opioid, protonitazene
The PRN will be launching The Know website soon, stay tuned for details about where you can find links to alerts released across Australia!
Be a part of The Know Community
The PRN has developed The Know Community, an online professional community platform, for PRN stakeholders from each jurisdiction to collaborate and share information on alerts and emerging drugs.
If you are interested in joining the platform, it is via referral only. Email PRN@nccred.org with the following information, name, email, organisation and mention this newsletter. The PRN will create an account for you to activate.
Join the PRN team!
If you are interested in working on the PRN, NCCRED is actively recruiting for a PRN Lead and Post-Doctoral Fellow, Post-Doctoral Fellow (Emerging Drugs).
The National Centre for Clinical Research on Emerging Drugs is made up of a consortium of the following four institutions
|
|
Stay up-to-date and in the know - follow us on social media
